Dr. Agarwal's Eye Hospital Limited (BOM:526783)
India flag India · Delayed Price · Currency is INR
5,150.75
+63.30 (1.24%)
At close: May 22, 2026

BOM:526783 Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Revenue
4,7093,9723,1932,6812,012
Other Revenue
58.2----
4,7673,9723,1932,6812,012
Revenue Growth (YoY)
20.03%24.38%19.10%33.24%43.39%
Cost of Revenue
2,5462,2601,8681,576649.3
Gross Profit
2,2211,7121,3251,1051,363
Selling, General & Admin
-147.8127.7106.371.2
Other Operating Expenses
709.8370.4282.4246.1714.8
Operating Expenses
1,166919.9678.3556.5989.9
Operating Income
1,055792.1646.8548.3372.9
Interest Expense
-118.9-123.6-71-68-61.2
Interest & Investment Income
-8.219.57.85.4
Currency Exchange Gain (Loss)
----1.1-0.1
Other Non Operating Income (Expenses)
0.15.712.34.33.9
EBT Excluding Unusual Items
936.1682.4607.6491.3320.9
Gain (Loss) on Sale of Investments
-8.8---
Gain (Loss) on Sale of Assets
--1.6-2.30.32.2
Other Unusual Items
-17.417.22.4-
Pretax Income
936.1707622.5494323.1
Income Tax Expense
235.1160.5158.9124.882.1
Net Income
701546.5463.6369.2241
Net Income to Common
701546.5463.6369.2241
Net Income Growth
28.27%17.88%25.57%53.20%-
Shares Outstanding (Basic)
55555
Shares Outstanding (Diluted)
55555
Shares Change (YoY)
1.45%----
EPS (Basic)
147.02116.2898.6478.5551.28
EPS (Diluted)
147.02116.2898.6478.5551.28
EPS Growth
26.44%17.88%25.57%53.19%-
Free Cash Flow
467.5-83.8184.5-7.299.5
Free Cash Flow Per Share
98.05-17.8339.26-1.5321.17
Dividend Per Share
-6.0005.0003.0003.000
Dividend Growth
-20.00%66.67%--
Gross Margin
46.59%43.11%41.50%41.21%67.73%
Operating Margin
22.13%19.95%20.26%20.45%18.53%
Profit Margin
14.71%13.76%14.52%13.77%11.98%
Free Cash Flow Margin
9.81%-2.11%5.78%-0.27%4.95%
EBITDA
1,5111,020779.5643.8489
EBITDA Margin
31.70%25.68%24.41%24.01%24.30%
D&A For EBITDA
456.4227.9132.795.5116.1
EBIT
1,055792.1646.8548.3372.9
EBIT Margin
22.13%19.95%20.26%20.45%18.53%
Effective Tax Rate
25.11%22.70%25.53%25.26%25.41%
Revenue as Reported
4,7674,0223,2432,6972,025
Source: S&P Global Market Intelligence. Standard template. Financial Sources.